Zheng Xing Xing Ye Ri Bao·2025-11-07 08:37Market Overview - The pharmaceutical commercial sector increased by 0.81% on November 7, with HeFu China leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Top Performers - HeFu China (603122) closed at 15.77, up 9.97% with a trading volume of 1.2677 million shares and a transaction value of 1.781 billion [1] - LuYan Pharmaceutical (002788) closed at 9.61, up 3.00% with a trading volume of 442,200 shares and a transaction value of 418 million [1] - HuaRen Health (301408) closed at 14.23, up 2.74% with a trading volume of 155,100 shares and a transaction value of 217 million [1] Underperformers - JianFa ZhiXin (301584) closed at 31.22, down 4.23% with a trading volume of 110,900 shares and a transaction value of 348 million [2] - BaiYang Pharmaceutical (301015) closed at 24.25, down 1.78% with a trading volume of 51,000 shares and a transaction value of 124 million [2] - RunDa Medical (603108) closed at 15.90, down 1.55% with a trading volume of 171,300 shares and a transaction value of 272 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 269 million from institutional investors, while retail investors saw a net inflow of 256 million [2][3] - The net inflow from speculative funds was 13.51 million [2][3] Individual Stock Capital Flow - YiFeng Pharmacy (603939) had a net inflow of 28.4554 million from institutional investors, while it faced a net outflow of 2.9266 million from speculative funds and a net outflow of 25.5288 million from retail investors [3] - Shanghai Pharmaceutical (601607) saw a net inflow of 26.6640 million from institutional investors, with net outflows from both speculative and retail investors [3]